retatrutide fda status 2025 Retatrutide: What It Is & How This New Drug Works Retatrutide for Weight Loss: What
Description
In preclinical models this combination showed an additive effect
DPP-4 inhibitors are also used therapeutically to enhance endogenous GLP-1 activity, but only for glycemic control, as they are weight-neutral
What are common side effects clinicians should watch for
Tolerance is individual
These once-weekly injectable peptide medications are key elements in known FDA-approved brands that treat diabetes, obesity and excess weight
